exclusive marketing rights? lol - please.
you wanna get well or ya wanna get $fouched?
- "Hydroxychloroquine's main function within this treatment approach is to allow zinc to enter the cell. Zinc is the virus killer,
- inhibit the recently emerged novel coronavirus (2019-nCoV)
- cued up ...
Newly Published Outpatient Study Finds that Early Use of Zinc, Hydroxychloroquine and Azithromycin Is Associated with Less Hospitalizations and Death
https://www.prnewswire.com/news-rel...ess-hospitalizations-and-death-301094237.html
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
https://www.nature.com/articles/s41421-020-0156-0
HCQ is a safe and successful anti-inflammatory agent that has been used extensively in autoimmune diseases and can significantly decrease the production of cytokines and, in particular, pro-inflammatory factors. Therefore, in COVID-19 patients, HCQ may also contribute to attenuating the inflammatory response. In conclusion, our results show that HCQ can efficiently inhibit SARS-CoV-2 infection in vitro. In combination with its anti-inflammatory function, we predict that the drug has a good potential to combat the disease.
-
Published: 04 February 2020
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Our findings reveal that remdesivir and chloroquine are highly effective in the control of 2019-nCoV infection in vitro. Since these compounds have been used in human patients with a safety track record and shown to be effective against various ailments, we suggest that they should be assessed in human patients suffering from the novel coronavirus disease.
https://www.nature.com/articles/s41422-020-0282-0
-
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009768s037s045s047lbl.pdf
"These three medications are affordable, available in pill form, and work in synergy against COVID-19," said Zelenko. "Hydroxychloroquine's main function within this treatment approach is to allow zinc to enter the cell. Zinc is the virus killer, and azithromycin prevents secondary bacterial infection in the lungs and reduces the risk of pulmonary complications."
"The world seems to have forgotten common medical knowledge: that we want to treat any patient with an infectious disease as soon as possible," said Derwand. "What differentiates this study is that patients were prescribed these medications early, in the outpatient setting. Dr. Zelenko treated his risk stratified patients immediately and didn't wait for the disease to intensify."
"The well-tolerated 5-day triple therapy resulted in a significantly lower hospitalization rate and less fatalities with no reported cardiac side effects compared with relevant public reference data of untreated patients," said Sholz. "The magnitude of the results can substantially elevate the relevance of early use, low dose hydroxychloroquine, especially in combination with zinc. This data can be used to inform ongoing pandemic response policies as well as future clinical trials."
"It's unfortunate much of the news coverage surrounding hydroxychloroquine has been negative," Zelenko added. "This study suggests that when taken early and together with zinc and azithromycin, this cost-effective drug can be part of the solution to the pandemic."
